Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

common-default.jpeg

Terms / Notices

Cookies

Privacy Policy

Reporting Hotline

Attorney Advertising

Alumni

  Linkedin

MoFo LinkedIN

  Facebook

MoFo Facebook

YouTube

MoFo Youtube

Morrison Foerster - Footer

Liz Newman

You have not solved the recaptcha challenge yet or session expired, try again.

Email Disclaimer

Disclaimer

Unsolicited e-mails and information sent to Morrison Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison Foerster. If you are not already a client of Morrison Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Community

Offices

Careers

Stay Connected

newman_liz_blog_150x150.png

newman_liz_common_640x280.jpg

newman_liz_heroretina_2700x1160.jpg

newman_liz_mobileretina_750x1040.jpg

newman_liz_social_600x600.jpg

Dr. Elizabeth (Liz) Newman focuses her work on patent  drafting and assisting prosecution. She also has experience in IP due diligence  inquiries, including freedom-to-operate analyses, with an emphas

Liz Newman Ph.D.

<h3>Sorry, we weren’t able to find the terms you entered.</h3>Please try a different term or keyword.

People

Capabilities

Resources

Not Found Cards

Case Studies

2024 Morrison Foerster and HBC Advanced Topics in Patent Law

2023 Advanced Topics in Patent Law

Advanced Topics in Patent Law

COVID-19 Year Two: Looking Back/Looking Forward

Events

Experience

Law360

3 Takeaways From FDA Cell And Gene Therapy Draft Guidance

Three Things to Know about FDA’s Newest Draft Guidance on Cell & Gene Therapies

Recent Updates on Use of Post-filing Data as Evidence to Support Patentability

The “Big Bang” for Sequence Listings: New Requirements in Place July 1, 2022

Insights

News

Podcasts

Life Sciences + Healthcare

Biotechnology + Pharmaceuticals

San Diego

Patent Strategy + Prosecution

IP Due Diligence

enewman@mofo.com

Liz Newman, Ph.D.

(858) 314-7704

Video + Audio